Vol 25, No 5 (2018)
EDITORIALS
Published online: 2018-10-30

open access

Page views 2222
Article views/downloads 920
Get Citation

Connect on Social Media

Connect on Social Media

Routine angiographic follow-up for left main percutaneous coronary intervention: Back to the old times?

Marcelo Sanmartin, Ramesh Daggubati
Pubmed: 30394513
Cardiol J 2018;25(5):571-573.

Abstract

Not available

Article available in PDF format

View PDF Download PDF file

References

  1. Jukema JW, Verschuren JJW, Ahmed TAN, et al. Restenosis after PCI. Part 1: pathophysiology and risk factors. Nat Rev Cardiol. 2011; 9(1): 53–62.
  2. ten Berg JM, Kelder JC, Suttorp MJ, et al. Influence of planned six-month follow-up angiography on late outcome after percutaneous coronary intervention: a randomized study. J Am Coll Cardiol. 2001; 38(4): 1061–1069.
  3. Uchida T, Popma J, Stone GW, et al. The clinical impact of routine angiographic follow-up in randomized trials of drug-eluting stents: a critical assessment of "oculostenotic" reintervention in patients with intermediate lesions. JACC Cardiovasc Interv. 2010; 3(4): 403–11.
  4. Aurigemma C, Burzotta F, Porto I, et al. Clinical impact of routine angiographic follow-up after percutaneous coronary interventions on unprotected left main. Cardiol J. 2018; 25(5): xx–xx.
  5. Biondi-Zoccai GGL, Giraudi E, Moretti C, et al. Impact of routine angiographic follow-up after percutaneous coronary drug-eluting stenting for unprotected left main disease: the Turin Registry. Clin Res Cardiol. 2010; 99(4): 235–242.
  6. D'Ascenzo F, Iannaccone M, Pavani M, et al. Planned angiographic control versus clinical follow-up for patients with unprotected left main stem stenosis treated with second generation drug-eluting stents: A propensity score with matching analysis from the FAILS (failure in left main with second generation stents-Cardiogroup III Study). Catheter Cardiovasc Interv. 2017 [Epub ahead of print].
  7. Morice MC, Serruys PW, Kappetein AP, et al. Five-Year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial. Circulation. 2014; 129(23): 2388–2394.
  8. Stone G, Sabik J, Serruys P, et al. Everolimus-eluting stents or bypass surgery for left main coronary artery disease. N Engl J Med. 2016; 375(23): 2223–2235.
  9. Shiomi H, Morimoto T, Kitaguchi S, et al. The ReACT Trial. JACC: Cardiovascular Interventions. 2017; 10(2): 109–117.
  10. Andreou I, Stone PH. In-stent atherosclerosis at a crossroads: neoatherosclerosis … or paleoatherosclerosis? Circulation. 2016; 134(19): 1413–1415.
  11. Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2018 [Epub ahead of print].
  12. Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2011; 124(23): e574–e651.